Oncomatryx Biopharma SL:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Oncomatryx Biopharma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11186
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oncomatryx Biopharma SL (Oncomatryx) is a developer of precision drugs. The company offers precision drugs that targets proteins located in the tumor environment. It develops therapeutic antibody-drug conjugates, antibodies, and human-derived proteins, which targets tumor associated stroma. Oncomatryx’s products comprise DMTX invaScan, DMTX bladderScan, DMTX breastScan, and companion diagnostics, among others. The company offers sensitive and specific monoclonal antibodies for the diagnosis of invasive carcinomas, among others. It markets its products through a network of distributors in Spain and abroad. Oncomatryx is headquartered in Derio, Spain.

Oncomatryx Biopharma SL – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Oncomatryx Biopharma SL, Medical Devices Deals, 2012 to YTD 2018 9
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Oncomatrix Enters Into Co-Development Agreement With University Of Stuttgart For Tumor Metastases Drugs 11
Licensing Agreements 12
Oncomatrix Enters Into Licensing Agreement With National Jewish Health For Cystatin-C Intellectual Property 12
Equity Offering 13
Oncomatryx Biopharma Raises USD5 Million in Equity Financing 13
Oncomatryx Biopharma SL – Key Competitors 14
Oncomatryx Biopharma SL – Key Employees 15
Oncomatryx Biopharma SL – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Key Facts 2
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oncomatryx Biopharma SL, Deals By Therapy Area, 2012 to YTD 2018 8
Oncomatryx Biopharma SL, Medical Devices Deals, 2012 to YTD 2018 9
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Oncomatrix Enters Into Co-Development Agreement With University Of Stuttgart For Tumor Metastases Drugs 11
Oncomatrix Enters Into Licensing Agreement With National Jewish Health For Cystatin-C Intellectual Property 12
Oncomatryx Biopharma Raises USD5 Million in Equity Financing 13
Oncomatryx Biopharma SL, Key Competitors 14
Oncomatryx Biopharma SL, Key Employees 15

List of Figures
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oncomatryx Biopharma SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Oncomatryx Biopharma SL, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Oncomatryx Biopharma SL:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Valeo SA (FR):企業の財務・戦略的SWOT分析
    Valeo SA (FR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Civitas Solutions Inc:企業の戦略・SWOT・財務情報
    Civitas Solutions Inc - Strategy, SWOT and Corporate Finance Report Summary Civitas Solutions Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Acorda Therapeutics, Inc.:企業のM&A・事業提携・投資動向
    Acorda Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Acorda Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Telkom SA SOC Limited (TKG):企業の財務・戦略的SWOT分析
    Telkom SA SOC Limited (TKG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Dexus Property Group:企業のM&A・事業提携・投資動向
    Dexus Property Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dexus Property Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Europaeische Reiseversicherung AG:企業の戦略・SWOT・財務情報
    Europaeische Reiseversicherung AG - Strategy, SWOT and Corporate Finance Report Summary Europaeische Reiseversicherung AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Craneware plc (CRW):企業の財務・戦略的SWOT分析
    Summary Craneware plc (Craneware) is a healthcare technology company that provides revenue integrity solutions. The company provides patient engagement, charge capture and pricing; coding integrity, and revenue recovery and retention products, chargemaster tool kit, online reference tool kit, physic …
  • Dot Foods, Inc.:企業の戦略・SWOT・財務情報
    Dot Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dot Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Fluidigm Corp (FLDM):医療機器:M&Aディール及び事業提携情報
    Summary Fluidigm Corp (Fluidigm), formerly Mycometrix Corp, develops, manufactures, and markets life science analytical and preparatory systems for mass cytometry, high-throughput genomics, and single-cell genomics markets. The company offers analytical systems and instruments, preparatory instrumen …
  • Nihon Kohden Corporation:企業の戦略・SWOT・財務情報
    Nihon Kohden Corporation - Strategy, SWOT and Corporate Finance Report Summary Nihon Kohden Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • BL&H Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary BL&H Co Ltd (BL&H), a subsidiary of STADA Pharmaceuticals (Asia) Ltd is a drug company that manufactures and markets diagnostic test kits and drugs. The company offers products including aridol bronchial challenge test kit, cetraxal plus ear drop, al-sense amniotic leak test kit, DC bead-dru …
  • Emerald Expositions, Inc. (EEX):企業の財務・戦略的SWOT分析
    Emerald Expositions, Inc. (EEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • MILEI GmbH:企業の戦略・SWOT・財務情報
    MILEI GmbH - Strategy, SWOT and Corporate Finance Report Summary MILEI GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Mitsubishi Tanabe Pharma Corporation:企業のM&A・事業提携・投資動向
    Mitsubishi Tanabe Pharma Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsubishi Tanabe Pharma Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • B&M European Value Retail S.A.:戦略・SWOT・企業財務分析
    B&M European Value Retail S.A. - Strategy, SWOT and Corporate Finance Report Summary B&M European Value Retail S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • LaSalle Hotel Properties:企業のM&A・事業提携・投資動向
    LaSalle Hotel Properties - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LaSalle Hotel Properties Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Nizhnekamskneftekhim (NKNC):企業の財務・戦略的SWOT分析
    Nizhnekamskneftekhim (NKNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Laredo Petroleum Inc (LPI):石油・ガス:M&Aディール及び事業提携情報
    Summary Laredo Petroleum Inc (Laredo), formerly known as Laredo Petroleum Holdings, Inc., is an independent energy company that acquires assets, and explores for, develops and produces oil and natural gas properties. It also gathers oil and liquids-rich natural gas from its properties. The company h …
  • CSS Industries, Inc. (CSS):企業の財務・戦略的SWOT分析
    CSS Industries, Inc. (CSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Abano Healthcare Group Ltd (ABA)-製薬・医療分野:企業M&A・提携分析
    Summary Abano Healthcare Group Ltd (Abano Healthcare), formerly ElderCare New Zealand Ltd is a healthcare service provider that offers Dental, Audiology, Radiology and medical services. The company also operates business in community pathology and radiology sector. It operates businesses in sectors …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆